Collective statement from consumer and patient representative groups on Pharmac’s proposal to decline some medicine funding applications on the Options for Investment list.

Myeloma New Zealand and other consumer and patient representative groups have sent a collective statement to Pharmac regarding their proposal to decline some of the medicine funding applications on the Options
for Investment list.  You can read this statement on our submissions page. 

Myeloma NZ also sent our own feedback to Pharmac on the proposal. You can read this and the proposal here.